First Time Loading...

Aramark
NYSE:ARMK

Watchlist Manager
Aramark Logo
Aramark
NYSE:ARMK
Watchlist
Price: 31.87 USD 2.15% Market Closed
Updated: Apr 20, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

12.4B
-26%
Assets
Growth Rates:
1 Year
-19%
3 Years
-14%
5 Years
-10%
7 Years
+20%
10 Years
+21%
9.6B
-27%
Liabilities
Growth Rates:
1 Year
-21%
3 Years
-19%
5 Years
-9%
7 Years
+18%
10 Years
+12%
2.8B
-23%
Equity
Growth Rates:
1 Year
-9%
3 Years
+6%
5 Years
-12%
7 Years
+27%
10 Years
+69%

Balance Sheet Decomposition
Aramark

12.4B
Assets
9.6B
Liabilities
12.4B
Assets
9.6B
Liabilities
Current Assets 3.2B
Cash & Short-Term Investments 295.6m
Receivables 2.2B
Other Current Assets 673m
Non-Current Assets 9.3B
PP&E 2.1B
Intangibles 6.5B
Other Non-Current Assets 678.1m
Current Liabilities 2.5B
Accounts Payable 1.1B
Accrued Liabilities 1.4B
Other Current Liabilities 41.5m
Non-Current Liabilities 7.1B
Long-Term Debt 5.9B
Other Non-Current Liabilities 1.2B

Balance Sheet
Aramark

Rotate your device to view
Balance Sheet
Currency: USD
Oct-2014 Oct-2015 Sep-2016 Sep-2017 Sep-2018 Sep-2019 Oct-2020 Oct-2021 Sep-2022 Sep-2023
Assets
Cash & Cash Equivalents
112
122
153
239
215
247
2 509
533
329
1 963
Cash Equivalents
112
122
153
239
215
247
2 509
533
329
1 963
Short-Term Investments
0
0
0
0
0
0
0
0
78
111
Total Receivables
1 582
1 445
1 476
1 616
1 790
1 807
1 555
1 772
2 159
2 374
Accounts Receivables
1 582
1 445
1 476
1 616
1 790
1 807
1 431
1 749
2 148
2 364
Other Receivables
0
0
0
0
0
0
124
23
11
10
Inventory
554
575
587
611
725
411
436
413
552
578
Other Current Assets
217
237
277
188
171
193
175
181
173
194
Total Current Assets
2 465
2 379
2 493
2 653
2 901
2 658
4 676
2 899
3 292
5 220
PP&E Net
997
959
1 023
1 042
1 378
2 182
2 602
2 626
2 624
2 721
PP&E Gross
997
0
1 023
1 042
1 378
2 182
2 602
2 626
2 624
2 721
Accumulated Depreciation
1 358
0
1 511
1 635
1 820
2 759
3 063
3 301
3 485
3 683
Intangible Assets
1 253
1 112
1 112
1 121
2 137
2 034
1 933
2 029
2 114
2 043
Goodwill
4 590
4 559
4 629
4 716
5 611
5 519
5 344
5 487
5 515
5 580
Note Receivable
0
0
0
0
0
0
28
32
26
24
Long-Term Investments
0
0
0
0
0
0
263
405
405
185
Other Long-Term Assets
1 151
1 187
1 326
1 475
1 693
1 344
867
898
1 106
1 099
Other Assets
4 590
4 559
4 629
4 716
5 611
5 519
5 344
5 487
5 515
5 580
Total Assets
10 456
N/A
10 196
-2%
10 582
+4%
11 006
+4%
13 720
+25%
13 736
+0%
15 713
+14%
14 376
-9%
15 082
+5%
16 871
+12%
Liabilities
Accounts Payable
984
845
847
956
1 019
1 000
663
919
1 323
1 406
Accrued Liabilities
1 303
1 243
1 022
1 038
1 141
1 290
1 292
1 539
1 551
1 666
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
90
81
47
78
31
70
100
59
65
1 597
Other Current Liabilities
2
11
269
296
299
346
292
341
347
361
Total Current Liabilities
2 379
2 181
2 185
2 368
2 490
2 705
2 347
2 857
3 286
5 030
Long-Term Debt
5 356
5 185
5 224
5 190
7 213
6 612
9 179
7 393
7 346
6 667
Deferred Income Tax
0
0
608
571
503
520
399
383
501
610
Minority Interest
10
10
10
10
10
10
10
9
9
8
Other Liabilities
993
937
395
408
474
569
1 042
1 010
911
843
Total Liabilities
8 738
N/A
8 313
-5%
8 421
+1%
8 547
+1%
10 691
+25%
10 416
-3%
12 977
+25%
11 653
-10%
12 053
+3%
13 159
+9%
Equity
Common Stock
3
3
3
3
3
3
3
3
3
3
Retained Earnings
382
229
34
247
711
1 107
532
328
407
964
Additional Paid In Capital
2 575
2 785
2 922
3 015
3 132
3 236
3 416
3 533
3 682
3 826
Treasury Stock
371
509
549
682
725
809
908
933
951
982
Other Equity
106
167
181
124
91
217
307
208
112
98
Total Equity
1 718
N/A
1 883
+10%
2 161
+15%
2 459
+14%
3 030
+23%
3 320
+10%
2 736
-18%
2 723
0%
3 030
+11%
3 713
+23%
Total Liabilities & Equity
10 456
N/A
10 196
-2%
10 582
+4%
11 006
+4%
13 720
+25%
13 736
+0%
15 713
+14%
14 376
-9%
15 082
+5%
16 871
+12%
Shares Outstanding
Common Shares Outstanding
234
240
245
246
247
248
253
256
259
261

See Also

Summary
ARMK intrinsic value, competitors valuation, and company profile.
DCF Valuation
ARMK stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ARMK stock valuation using valuation multiples.
Wall Street Estimates
ARMK price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ARMK stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 129,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.